Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia
Sponsor: Tanta University
Summary
The current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Official title: The Potential Role of N-Acetyl Cysteine or Alpha-Lipoic Acid as Adjuvant Therapies in the Treatment of Patients With Beta Thalassemia
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2025-08-30
Completion Date
2026-01-30
Last Updated
2025-09-05
Healthy Volunteers
No
Conditions
Interventions
Iron chelating intervention
JADENU is indicated for the treatment of chronic iron overload due to blood transfusions.
N Acetyl cysteine 600mg
N-acetyl cysteine (NAC) 600 mg will be administered orally once daily for 12 weeks.
Alpha Lipoic Acid 600 MG Oral Tablets
Alpha lipoic acid (ALA) 600 mg will be administered orally once daily for 12 weeks.
Locations (1)
Faculty of Pharmacy - Tanta University
Tanta, Egypt